DIH Holding US, Inc.

DHAI

Healthcare Medical Devices

DIH Holding US, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $62.9 million, down 2.50% from fiscal 2024.

Revenue
−30.7%
EPS
+43.1%
Free cash flow
−167.9%

Quarter to March 2025, against a year earlier

0.00 0.00 NaN
Market cap
$1.6M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
4/9
ROIC
0.00%
Net debt / EBITDA
−1.5×
Dividend safety
n/a
Older periods Jun '24 Sep '24 Dec '24 Mar '25
ROE

+8 more TTM periods

38.14% 27.39% 41.29% 24.90%
ROA
(6.95%) (12.65%) (23.03%) (27.77%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
46.59% 33.14% 45.82% 41.04%
Average Days of Receivables
67.60 68.42 53.94 39.00
Free Cash Flow per Share
3.40 2.00 2.67 (2.98)
Free Cash Flow
4.70 2.77 3.70 (4.68)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026